Cognitive impairment (CI) may occur in clinically isolated syndrome (CIS) patients. While the relationship between CI and magnetic resonance imaging (MRI) has been investigated extensively in multiple sclerosis (MS), MRI correlates of CI in CIS patients are unknown. To investigate the evolution of CI and to determine brain MRI structural correlates associated with CI in CIS patients. This prospective 24-month observational study examined 81 CIS patients treated with 30 µg of intramuscular interferon beta 1a once a week. MRI acquisition and neuropsychological (NP) assessment were performed at baseline, 6, 12 and 24 months. Participants were tested with Czech-validated version of Minimal Assessment of Cognitive Function in MS battery and MRI measures of lesion activity and burden, and global, tissue-specific and regional brain atrophy were performed. Over 24 months, 36 CIS patients developed clinically definite MS (CDMS). CI was observed in 10 (12.3 %) CIS patients at baseline and at the 24 months follow-up. Eight CIS patients changed their CI status over the follow-up (four improved and four worsened). No significant difference in development of CI was detected between stable CIS patients and those who developed CDMS. In multivariate regression and mixed-effect model analyses, no significant relationship was found between NP and MRI parameters. The lack of significant relationship between MRI metrics and cognition in this group of CIS patients could be attributed to several factors including the cognitive reserve, effect of disease-modifying therapy and relatively short follow-up period.

Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine and General University Hospital Charles University Prague Prague Czech Republic

Zobrazit více v PubMed

J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):443-6 PubMed

Arch Neurol. 2007 Aug;64(8):1157-61 PubMed

J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):38-43 PubMed

Curr Opin Neurol. 2011 Jun;24(3):244-9 PubMed

Ann Neurol. 2011 Feb;69(2):292-302 PubMed

Mult Scler. 2013 Oct;19(11):1478-84 PubMed

J Int Neuropsychol Soc. 2010 Sep;16(5):829-35 PubMed

Neuroimage. 2002 Sep;17(1):479-89 PubMed

PLoS One. 2013;8(1):e53996 PubMed

J Neurol Sci. 2006 Jun 15;245(1-2):77-85 PubMed

J Neurol Neurosurg Psychiatry. 2008 Nov;79(11):1236-44 PubMed

J Int Neuropsychol Soc. 2009 Jul;15(4):606-12 PubMed

Clin Neuropsychol. 2010 Oct;24(7):1131-45 PubMed

Arch Neurol. 2006 Sep;63(9):1301-6 PubMed

Neurology. 2012 Oct 23;79(17):1754-61 PubMed

J Int Neuropsychol Soc. 2006 Jul;12(4):549-58 PubMed

Mult Scler. 2006 Apr;12(2):187-95 PubMed

Clin Neuropsychol. 2012;26(7):1186-200 PubMed

Ann Neurol. 2005 Dec;58(6):840-6 PubMed

J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1157-9 PubMed

Mult Scler. 2007 Sep;13(8):1004-10 PubMed

J Neurol Sci. 2008 Apr 15;267(1-2):100-6 PubMed

Brain. 1997 Feb;120 ( Pt 2):257-69 PubMed

Mult Scler. 2010 Jan;16(1):62-7 PubMed

Mult Scler. 2007 Jan;13(1):124-7 PubMed

Radiology. 2013 Sep;268(3):831-41 PubMed

Clin Neuropsychol. 2002 Aug;16(3):381-97 PubMed

Mult Scler. 2012 May;18(5):662-8 PubMed

Neurology. 2004 Jul 13;63(1):89-93 PubMed

Mult Scler. 2013 Aug;19(9):1122-7 PubMed

Nat Rev Neurol. 2011 May 10;7(6):332-42 PubMed

PLoS One. 2012;7(11):e50101 PubMed

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):859-64 PubMed

Neurology. 2013 May 7;80(19):1728-33 PubMed

J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):955-8 PubMed

Neurology. 2007 Sep 18;69(12):1213-23 PubMed

Mult Scler. 2012 Oct;18(10):1466-71 PubMed

J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):869-76 PubMed

PLoS One. 2013 Aug 01;8(8):e71058 PubMed

Mult Scler. 2009 Aug;15(8):998-1005 PubMed

Neurology. 1991 May;41(5):685-91 PubMed

Ann Neurol. 2000 Dec;48(6):885-92 PubMed

Neuroimage. 2014 Apr 15;90:207-17 PubMed

Neurology. 1989 Feb;39(2 Pt 1):161-6 PubMed

J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):773-80 PubMed

J Neurol Sci. 2013 Jul 15;330(1-2):56-60 PubMed

Mult Scler. 2011 Jun;17(6):755-8 PubMed

Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis

Cognitive clinico-radiological paradox in early stages of multiple sclerosis

Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis

Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis

Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome